GX EXCELLA
LIVE

Serial Number

88238636

Owner

Gerresheimer Glas GmbH

Attorney

Alexander P. Montgomery

Filing Date

Dec 21, 2018

Add to watchlist:

No watchlists yet
View on USPTO

GX EXCELLA Trademark

Serial Number: 88238636 • Registration: 6325047

GX EXCELLA is a trademark filed by Gerresheimer Glas GmbH on December 21, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 20 (Furniture), Class 21 (Housewares). The application is currently registered and active.

Owner Contact Info

Gerresheimer Glas GmbH (23 trademarks)

Klaus-Bungert-Str. 4

Entity Type: 16

Trademark Details

Filing Date

December 21, 2018

Registration Date

April 20, 2021

Published for Opposition

November 3, 2020

Goods & Services

Dosing systems comprised of devices for dispensing pre-determined dosages of liquids or solids used in laboratories; laboratory supplies, namely, test tubes pipettes, flasks for laboratory use, volumetric flasks, vials for laboratory use, insulated bottles for laboratory use, plates for laboratory use, laboratory beakers, laboratory trays, laboratory filters, laboratory storage tubes, dosage dispensers, cuvettes; measuring containers, namely, containers specially design to carry measuring equipment used in laboratories; laboratory glass, namely, glass tubes for scientific purposes flasks for laboratory use, volumetric flasks, vials for laboratory use, insulated bottles for laboratory use, plates for laboratory use, laboratory beakers, cuvettes; containers, packaging and application systems and administering devices of glass in the nature of test tubs, for use in laboratories

Containers and packaging containers of plastic for commercial use in particular for the perfume, cosmetics and pharmaceutical industries, for use in medical technology, laboratories, and for the food and drink industries; cans of plastic for the aforesaid goods used as commercial containers; closures for containers, not of metal

Containers, packaging and application systems and administering devices of glass, and parts, pre-products and accessories therefor, in particular for the perfume, cosmetics and pharmaceutical industries, for use in medical technology, the food and drink industries in the nature of bottles sold empty; bottles sold empty, drinking glasses, flasks, glass vials sold empty, glass cartridges for medication sold empty, flacons in the nature of bottles sold empty, glass tubes not for scientific purposes, dishes; pre-products for containers, packaging and application systems and administering devices of glass for use in laboratories in the nature of industrial packaging containers of glass

Medical instruments and apparatus, in particular, syringes featuring safety and administering accessories; medical instruments and apparatus, in particular, infusion systems, consisting primarily of infusion sets, medical infusion and injection devices for administering drugs, infusion apparatuses for infusion of blood, blood substitutes, plasma and infusion solutions, and infusion pumps for delivering measured amounts of solutions into the bloodstream over time; medical instruments and apparatus, in particular, transfusion systems, consisting primarily of transfusion sets, transfusion apparatuses for transfusion of blood, blood substitutes, plasma and other transfusion media, and medical tubing for transfusions; and medical instruments and apparatus, in particular, inhalation systems, consisting primarily of inhalers for medical purposes sold empty, particularly powder inhalers and capsule inhalers, and nebulizers for medical use, medical apparatus for facilitating the inhalation of pharmaceutical preparations, medical apparatus for administering medication in the form of an aerosol; dosing systems and administering devices for medical purposes in the nature of medical tubing for administering drugs

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 20, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 28, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 28, 2025 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 12, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 12, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 20, 2021 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 14, 2021 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 19, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 28, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 16, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 2, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 2, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 2, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 12, 2020 RCCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2019 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 27, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 27, 2019 GNSL
SUSPENSION LETTER WRITTEN
Aug 27, 2019 CNSL
EXAMINER'S AMENDMENT ENTERED
Aug 27, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 27, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 27, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 27, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 2019 CRFA
ASSIGNED TO LIE
Aug 8, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 18, 2019 GPRN
PRIORITY ACTION E-MAILED
Mar 18, 2019 GPRA
PRIORITY ACTION WRITTEN
Mar 18, 2019 CPRA
ASSIGNED TO EXAMINER
Mar 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2019 NWOS
NEW APPLICATION ENTERED
Dec 25, 2018 NWAP